OverviewChartTechnicalNewsTraderScreen

Akari Therapeutics PLC/  US00972G2075  /

NASDAQ
03/05/2024  21:59:13 Chg. -0.1100 Volume Bid23:38:44 Ask23:38:44 High Low
1.3600USD -7.48% 20,772
Turnover: 26,822.8321		 1.1500Bid Size: 100 1.7500Ask Size: 10,000 1.5900 1.3300
GlobeNewswire 01/05 Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics
GlobeNewswire 01/05 Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merge...
GlobeNewswire 01/05 Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merge...
GlobeNewswire 15/04 Akari Therapeutics to Present PAS-Nomacopan Pre-Clinical Electroretinography (ERG) Data at ARVO 2024
GlobeNewswire 01/04 Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights
GlobeNewswire 15/03 SHAREHOLDER ALERT: The M&A Class Action Launches Investigation of the Merger – SDPI, MINM, SCX, AKTX
GlobeNewswire 15/03 SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates VIVK, MINM, SDPI, AKTX
GlobeNewswire 09/03 INVESTIGATION UPDATE: Halper Sadeh LLC Investigates IGT, AKTX, SDPI, VIVK
GlobeNewswire 08/03 Kuehn Law Encourages VIVK, HES, SDPI, and AKTX Investors to Contact Law Firm
GlobeNewswire 05/03 Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expande...
GlobeNewswire 05/03 Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expande...
GlobeNewswire 02/01 Akari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Pla...
GlobeNewswire 14/12/2023 Akari Therapeutics to Present at Biotech Showcase 2024
GlobeNewswire 01/12/2023 Akari Therapeutics Appoints Experienced Life Sciences Entrepreneur Samir R. Patel, M.D. to Board of ...
GlobeNewswire 16/11/2023 Akari Therapeutics Presents Poster on Progress in Pre-Clinical Development of Long-Acting PAS-Nomaco...
GlobeNewswire 06/11/2023 Akari Therapeutics to Present a Poster on Pre-Clinical Development of Long-Acting PAS-Nomacopan as a...
GlobeNewswire 04/10/2023 Presenting on the Emerging Growth Conference 63 Day 2 on October 5 Register Now
GlobeNewswire 03/10/2023 Presenting on the Emerging Growth Conference 63 Day 1 on October 4 Register Now
GlobeNewswire 29/09/2023 Akari Therapeutics Reports First Half 2023 Financial Results and Highlights
GlobeNewswire 27/09/2023 Akari Therapeutics to Present at Emerging Growth Conference
GlobeNewswire 21/09/2023 Akari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Pla...
GlobeNewswire 19/09/2023 Akari Therapeutics to Host Key Opinion Leader Webinar on Hematopoietic Stem Cell Transplant-Related ...
GlobeNewswire 05/09/2023 Akari Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
GlobeNewswire 18/08/2023 Akari Therapeutics Announces Establishment of Boston U.S. Headquarters Office to Support Expanding O...
GlobeNewswire 15/08/2023 Akari Therapeutics, Plc Announces ADS Ratio Change